{"entity":{"type":"insider","cik":"0001932525","url":"/insider/0001932525","json_url":"/insider/0001932525.json","name":"Davis Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2022-11-23","last":"2024-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Davis Andrew","source":"filing","n_filings":7,"first_seen":"2022-11-23","last_seen":"2024-11-20"}],"transactions":[{"id":3228362,"accession":"0000950170-24-129228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-129228","line_url":"/filing/0000950170-24-129228#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001932525","owner_name":"Davis Andrew","owner_display_name":"Davis Andrew","owner_url":"/insider/0001932525","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5360.0,"shares_display":"5,360","price_per_share":4.08,"price_display":"4.08","price_state":"stated","total_value":21868.8,"total_display":"21,868.80","total_whole":"21,869","shares_owned_after":284685.0,"shares_owned_after_display":"284,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-20","scope":"insider"},{"id":3110520,"accession":"0000950170-24-063482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-063482","line_url":"/filing/0000950170-24-063482#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001932525","owner_name":"Davis Andrew","owner_display_name":"Davis Andrew","owner_url":"/insider/0001932525","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22725.0,"shares_display":"22,725","price_per_share":6.45,"price_display":"6.45","price_state":"stated","total_value":146576.25,"total_display":"146,576.25","total_whole":"146,576","shares_owned_after":288031.0,"shares_owned_after_display":"288,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider"},{"id":3108346,"accession":"0000950170-24-015548","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-015548","line_url":"/filing/0000950170-24-015548#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001932525","owner_name":"Davis Andrew","owner_display_name":"Davis Andrew","owner_url":"/insider/0001932525","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9846.0,"shares_display":"9,846","price_per_share":15.24,"price_display":"15.24","price_state":"stated","total_value":150053.04,"total_display":"150,053.04","total_whole":"150,053","shares_owned_after":208324.0,"shares_owned_after_display":"208,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider"},{"id":8000077,"accession":"0001209191-23-056446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056446","line_url":"/filing/0001209191-23-056446#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001932525","owner_name":"Davis Andrew","owner_display_name":"Davis Andrew","owner_url":"/insider/0001932525","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3287.0,"shares_display":"3,287","price_per_share":9.69,"price_display":"9.69","price_state":"stated","total_value":31851.03,"total_display":"31,851.03","total_whole":"31,851","shares_owned_after":217374.0,"shares_owned_after_display":"217,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-22","scope":"insider"},{"id":8022487,"accession":"0001209191-23-031873","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-031873","line_url":"/filing/0001209191-23-031873#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001932525","owner_name":"Davis Andrew","owner_display_name":"Davis Andrew","owner_url":"/insider/0001932525","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6305.0,"shares_display":"6,305","price_per_share":10.12,"price_display":"10.12","price_state":"stated","total_value":63806.6,"total_display":"63,806.60","total_whole":"63,807","shares_owned_after":219327.0,"shares_owned_after_display":"219,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider"},{"id":8182869,"accession":"0001209191-23-014276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-014276","line_url":"/filing/0001209191-23-014276#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001932525","owner_name":"Davis Andrew","owner_display_name":"Davis Andrew","owner_url":"/insider/0001932525","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1822.0,"shares_display":"1,822","price_per_share":11.31,"price_display":"11.31","price_state":"stated","total_value":20606.82,"total_display":"20,606.82","total_whole":"20,607","shares_owned_after":151396.0,"shares_owned_after_display":"151,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-01","scope":"insider"},{"id":8182868,"accession":"0001209191-23-014276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-014276","line_url":"/filing/0001209191-23-014276#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001932525","owner_name":"Davis Andrew","owner_display_name":"Davis Andrew","owner_url":"/insider/0001932525","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1751.0,"shares_display":"1,751","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":19978.91,"total_display":"19,978.91","total_whole":"19,979","shares_owned_after":153218.0,"shares_owned_after_display":"153,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-01","scope":"insider"},{"id":6988348,"accession":"0001209191-22-058607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-058607","line_url":"/filing/0001209191-22-058607#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001932525","owner_name":"Davis Andrew","owner_display_name":"Davis Andrew","owner_url":"/insider/0001932525","role":"Officer (SVP, Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3335.0,"shares_display":"3,335","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":38552.6,"total_display":"38,552.60","total_whole":"38,553","shares_owned_after":154213.0,"shares_owned_after_display":"154,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (SVP, Chief Business Officer)","n_filings":7,"first_seen":"2022-11-23","last_seen":"2024-11-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001932525","retrieved_at":"2026-08-26T12:36:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}